nausea and vomiting
Conditions
Interventions
High dose group:high dose remifentanil
Low dose group:Low dose remifentanil
Sponsors
The first affiliated hospital of Zhejiang university of traditional Chinese medicine.
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: With the consent of the hospital ethics Committee, informed consent and signature of the patients, 80 cases of patients undergoing elective gynecological endoscopic surgery were selected and randomly divided into high dose remifentanil group (group H) and low dose remifentanil group (group L), 40 cases in each group
Exclusion criteria
Exclusion criteria: Patients aged =60 years, malignant tumor patients, ASA>= grade ?, chronic pain and analgesic drug users, soybean oil or egg allergy, coronary heart disease,diabetes,smoker, Hb lower than 8g/L, asthma, hormone, opioid, antihistamine or antiemetics within 1 month before surgery, PONV history or sickness, body mass index greater than or equal to 28 or less than 18.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postoperative nause and vomiting; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative pain intensity using visual analog scale (VAS);the time to first postoperative analgesic requirement;cumulative volume of a patient- controlled analgesia (PCA) containing sulfentainil over 48 hr;intraoperative hemodynamicss; | — |
Countries
china
Contacts
Public ContactGuoxiaowen
Zhejiang Provincial Hospital of Traditional Chinese Medicine.
Outcome results
None listed